Chronic Weight Management

SEP 11, 2026 · PHASE 3 TRIAL

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ClinicalTrials.gov

This is an ongoing Phase 3 trial with no results reported; the registry record describes only planned enrollment, design, and primary outcome measures.

AUG 14, 2026 · PHASE 3 TRIAL

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

ClinicalTrials.gov

This is a clinical trial registry record with no reported results; the study is actively recruiting and outcomes have not yet been assessed or published.

AUG 14, 2026 · PHASE 3 TRIAL

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

ClinicalTrials.gov

This is a clinical trial registry record with no reported results; the study is actively recruiting and outcomes have not yet been analysed or posted.

AUG 10, 2026 · PHASE 3 TRIAL

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ClinicalTrials.gov

Phase 3 trial still recruiting with no results posted; registry record describes planned study design and endpoints only, not outcomes.